PlainRecalls
FDA Drug Low Class III Terminated

Diltiazem HCl Extended-release Capsules, USP, 120 mg, packaged in 80 Capsules (8 x 10) blister cards per carton, Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, NDC 51079-947-08.

Reported: July 23, 2014 Initiated: July 3, 2014 #D-1435-2014

Product Description

Diltiazem HCl Extended-release Capsules, USP, 120 mg, packaged in 80 Capsules (8 x 10) blister cards per carton, Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, NDC 51079-947-08.

Reason for Recall

Failed Impurities/Degradation Specifications: High out-of-specification results for a related compound obtained during routine stability testing.

Details

Units Affected
1,184 cartons
Distribution
Nationwide, Puerto Rico, and Guam.
Location
Rockford, IL

Frequently Asked Questions

What product was recalled?
Diltiazem HCl Extended-release Capsules, USP, 120 mg, packaged in 80 Capsules (8 x 10) blister cards per carton, Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, NDC 51079-947-08.. Recalled by Mylan Institutional, Inc. (d.b.a. UDL Laboratories). Units affected: 1,184 cartons.
Why was this product recalled?
Failed Impurities/Degradation Specifications: High out-of-specification results for a related compound obtained during routine stability testing.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 23, 2014. Severity: Low. Recall number: D-1435-2014.